Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2013

01.07.2013 | Original Article

miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma

verfasst von: Na Wang, Chao-qi Zhang, Jia-huan He, Xiao-fei Duan, Yuan-yuan Wang, Xiang Ji, Wen-qiao Zang, Min Li, Yun-yun Ma, Tao Wang, Guo-qiang Zhao

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

miR-21 is overexpressed in esophageal squamous cell carcinoma (ESCC) and is thought to be correlated with the development of the cancer. The target gene of miR-21 including FASL, TIMP3 and RECK is revealed by researchers. miR-21 may be involved in the tumorgenesis of ESCC by targeting FASL, TIMP3 and RECK.

Aims

The purpose of this study was to explore the mechanism of miR-21 in the development of ESCC.

Methods

miR-21 expression in ESCC and the matched non-malignant adjacent tissues (NMATs) was examined by qRT-PCR. Cell growth, cell apoptosis and cell invasion ability of EC9706 and EC-1 cells was examined after the cells were transfected with miR-21 inhibitor. The potential target genes of miR-21 including FASL, TIMP3 and RECK were examined by western blot and Luciferase reporter assay.

Results

miR-21 expression was increased significantly in ESCC tissues compared with NMAT. miR-21 down-regulation inhibits cell growth, cell invasion and induces cells to apoptosis. FASL, TIMP3 and RECK are direct targets of miR-21.

Conclusions

miR-21 down-regulation inhibits cell growth, invasion and induces cells to apoptosis by targeting FASL, TIMP3 and RECK genes.
Literatur
1.
Zurück zum Zitat Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–735.PubMedCrossRef Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–735.PubMedCrossRef
2.
Zurück zum Zitat Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS ONE. 2010;5:e14080.PubMedCrossRef Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS ONE. 2010;5:e14080.PubMedCrossRef
3.
Zurück zum Zitat D’Journo XB, Michelet P, Dahan L, et al. Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg. 2008;33:1117–1123.PubMedCrossRef D’Journo XB, Michelet P, Dahan L, et al. Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg. 2008;33:1117–1123.PubMedCrossRef
4.
Zurück zum Zitat Baxi SH, Burmeister B, Harvey JA, et al. Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imaging Radiat Oncol. 2008;52:583–587.PubMedCrossRef Baxi SH, Burmeister B, Harvey JA, et al. Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imaging Radiat Oncol. 2008;52:583–587.PubMedCrossRef
5.
Zurück zum Zitat Matsushima K, Isomoto H, Kohno S, et al. MicroRNAs and esophageal squamous cell carcinoma. Digestion. 2010;82:138–144.PubMedCrossRef Matsushima K, Isomoto H, Kohno S, et al. MicroRNAs and esophageal squamous cell carcinoma. Digestion. 2010;82:138–144.PubMedCrossRef
6.
Zurück zum Zitat Kimura S, Naganuma S, Susuki D, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010;23:1625–1633.PubMed Kimura S, Naganuma S, Susuki D, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010;23:1625–1633.PubMed
7.
Zurück zum Zitat Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135–144.PubMedCrossRef Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135–144.PubMedCrossRef
8.
Zurück zum Zitat Osman A. MicroRNAs in health and disease—basic science and clinical applications. Clin Lab. 2012;58:393–402.PubMed Osman A. MicroRNAs in health and disease—basic science and clinical applications. Clin Lab. 2012;58:393–402.PubMed
9.
10.
Zurück zum Zitat Li S, Liang Z, Xu L, et al. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem. 2012;360:147–158.PubMedCrossRef Li S, Liang Z, Xu L, et al. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem. 2012;360:147–158.PubMedCrossRef
11.
Zurück zum Zitat Zhao L, Chen X, Cao Y. New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai). 2011;43:831–839.CrossRef Zhao L, Chen X, Cao Y. New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai). 2011;43:831–839.CrossRef
12.
Zurück zum Zitat Liu J, Zheng M, Tang YL, et al. MicroRNAs, an active and versatile group in cancers. Int J Oral Sci. 2011;3:165–175.PubMedCrossRef Liu J, Zheng M, Tang YL, et al. MicroRNAs, an active and versatile group in cancers. Int J Oral Sci. 2011;3:165–175.PubMedCrossRef
13.
Zurück zum Zitat Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer. 2012;12:613–626.PubMedCrossRef Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer. 2012;12:613–626.PubMedCrossRef
14.
Zurück zum Zitat He B, Yin B, Wang B, et al. MicroRNAs in esophageal cancer (review). Mol Med Rep. 2012;6:459–465.PubMed He B, Yin B, Wang B, et al. MicroRNAs in esophageal cancer (review). Mol Med Rep. 2012;6:459–465.PubMed
15.
Zurück zum Zitat Feber A, Xi L, Pennathur A, et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg. 2011;91:1523–1530.PubMedCrossRef Feber A, Xi L, Pennathur A, et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg. 2011;91:1523–1530.PubMedCrossRef
16.
Zurück zum Zitat Gao W, Xu J, Liu L, et al. A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother. 2012;66:21–28.PubMedCrossRef Gao W, Xu J, Liu L, et al. A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother. 2012;66:21–28.PubMedCrossRef
17.
Zurück zum Zitat Schee K, Boye K, Abrahamsen TW, et al. Clinical relevance of microRNA mir-21, mir-31, mir-92a, mir-101, mir-106a and mir-145 in colorectal cancer. BMC Cancer. 2012;12:505.PubMedCrossRef Schee K, Boye K, Abrahamsen TW, et al. Clinical relevance of microRNA mir-21, mir-31, mir-92a, mir-101, mir-106a and mir-145 in colorectal cancer. BMC Cancer. 2012;12:505.PubMedCrossRef
18.
Zurück zum Zitat Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008;135:255–260.PubMedCrossRef Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008;135:255–260.PubMedCrossRef
19.
Zurück zum Zitat Mori Y, Ishiguro H, Kuwabara Y, et al. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Rep. 2009;2:235–239.PubMed Mori Y, Ishiguro H, Kuwabara Y, et al. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Rep. 2009;2:235–239.PubMed
20.
Zurück zum Zitat Mathé EA, Nguyen GH, Bowman ED, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res. 2009;15:6192–6200.PubMedCrossRef Mathé EA, Nguyen GH, Bowman ED, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res. 2009;15:6192–6200.PubMedCrossRef
21.
Zurück zum Zitat Ma WJ, Lv GD, Tuersun A, et al. Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma. Mol Biol Rep. 2011;38:3253–3260.PubMedCrossRef Ma WJ, Lv GD, Tuersun A, et al. Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma. Mol Biol Rep. 2011;38:3253–3260.PubMedCrossRef
22.
Zurück zum Zitat Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285:20281–20290.PubMedCrossRef Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285:20281–20290.PubMedCrossRef
23.
Zurück zum Zitat Nagao Y, Hisaoka M, Matsuyama A, et al. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol. 2012;25:112–121.PubMedCrossRef Nagao Y, Hisaoka M, Matsuyama A, et al. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol. 2012;25:112–121.PubMedCrossRef
24.
Zurück zum Zitat Zibert JR, Løvendorf MB, Litman T, et al. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58:177–185.PubMedCrossRef Zibert JR, Løvendorf MB, Litman T, et al. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58:177–185.PubMedCrossRef
25.
Zurück zum Zitat Reis ST, Pontes-Junior J, Antunes AA, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol. 2012;12:14.PubMedCrossRef Reis ST, Pontes-Junior J, Antunes AA, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol. 2012;12:14.PubMedCrossRef
26.
Zurück zum Zitat Rabien A, Ergün B, Erbersdobler A, et al. RECK overexpression decreases invasive potential in prostate cancer cells. Prostate. 2012;72:948–954.PubMedCrossRef Rabien A, Ergün B, Erbersdobler A, et al. RECK overexpression decreases invasive potential in prostate cancer cells. Prostate. 2012;72:948–954.PubMedCrossRef
27.
Zurück zum Zitat Han L, Yue X, Zhou X, et al. MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther. 2012;18:573–583.PubMedCrossRef Han L, Yue X, Zhou X, et al. MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther. 2012;18:573–583.PubMedCrossRef
28.
Zurück zum Zitat Gaur AB, Holbeck SL, Colburn NH, et al. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 2011;13:580–590.PubMedCrossRef Gaur AB, Holbeck SL, Colburn NH, et al. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 2011;13:580–590.PubMedCrossRef
29.
Zurück zum Zitat Lee JA, Lee HY, Lee ES, et al. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J Breast Cancer. 2011;14:269–275.PubMedCrossRef Lee JA, Lee HY, Lee ES, et al. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J Breast Cancer. 2011;14:269–275.PubMedCrossRef
30.
Zurück zum Zitat Zhong Z, Dong Z, Yang L, et al. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J Cancer Res Clin Oncol. 2012;138:1781–1788.PubMedCrossRef Zhong Z, Dong Z, Yang L, et al. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J Cancer Res Clin Oncol. 2012;138:1781–1788.PubMedCrossRef
31.
Zurück zum Zitat Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer. 2011;30:371–380.PubMed Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer. 2011;30:371–380.PubMed
32.
Zurück zum Zitat Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–359.PubMedCrossRef Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–359.PubMedCrossRef
33.
Zurück zum Zitat Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther. 2011;10:1224–1232. Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther. 2011;10:1224–1232.
34.
Zurück zum Zitat Xue LY, Ren LQ, Luo W, et al. Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi. 2007;87:150–154 (article in Chinese).PubMed Xue LY, Ren LQ, Luo W, et al. Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi. 2007;87:150–154 (article in Chinese).PubMed
35.
Zurück zum Zitat Ninomiya I, Kawakami K, Fushida S, et al. Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma. Oncol Rep. 2008;20:1489–1495.PubMed Ninomiya I, Kawakami K, Fushida S, et al. Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma. Oncol Rep. 2008;20:1489–1495.PubMed
36.
Zurück zum Zitat Li SL, Gao DL, Zhao ZH, et al. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J Gastroenterol. 2007;13:6076–6081.PubMedCrossRef Li SL, Gao DL, Zhao ZH, et al. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J Gastroenterol. 2007;13:6076–6081.PubMedCrossRef
Metadaten
Titel
miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma
verfasst von
Na Wang
Chao-qi Zhang
Jia-huan He
Xiao-fei Duan
Yuan-yuan Wang
Xiang Ji
Wen-qiao Zang
Min Li
Yun-yun Ma
Tao Wang
Guo-qiang Zhao
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2612-2

Weitere Artikel der Ausgabe 7/2013

Digestive Diseases and Sciences 7/2013 Zur Ausgabe

Stanford Multidisciplinary Seminars

Always a Suspect: CMV in Ulcerative Colitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.